Related references
Note: Only part of the references are listed.Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort
Milica Bozic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)
Epidemiology of chronic kidney disease: an update 2022
Csaba P. Kovesdy
KIDNEY INTERNATIONAL SUPPLEMENTS (2022)
Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism
Zeli Xiang et al.
FRONTIERS IN PHARMACOLOGY (2022)
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation
Nahid Tabibzadeh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome
Huixin Hao et al.
Aging-US (2021)
Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
Jordi Bover et al.
CLINICAL KIDNEY JOURNAL (2021)
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease
Yang Xu et al.
CLINICAL KIDNEY JOURNAL (2021)
Cardiovascular Disease in Chronic Kidney Disease Pathophysiological Insights and Therapeutic Options
Joachim Jankowski et al.
CIRCULATION (2021)
Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain
Enrique Alonso-Perez et al.
ADVANCES IN THERAPY (2021)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
Tally Naveh-Many et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease
S. Geng et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Mild to moderate chronic kidney disease and functional disability in community-dwelling older adults. The Cardiovascular risk profile in Renal patients of the Italian Health Examination Survey (CARHES) study
Giovanni Viscogliosi et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2019)
High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study
Per-Anton Westerberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study
Joshua D. Bundy et al.
ATHEROSCLEROSIS (2018)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
CKD Prevalence Varies across the European General Population
Katharina Bruck et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
Stuart M. Sprague et al.
AMERICAN JOURNAL OF NEPHROLOGY (2016)
Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study
Adam Shardlow et al.
PLOS MEDICINE (2016)
International Burden of Chronic Kidney Disease and Secondary Hyperparathyroidism: A Systematic Review of the Literature and Available Data
Elizabeth Hedgeman et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2015)
Fibroblast growth factor 23 and bone mineralisation
Yu-Chen Guo et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2015)
State of the Art for Measurement of Urine Albumin: Comparison of Routine Measurement Procedures to Isotope Dilution Tandem Mass Spectrometry
Lorin M. Bachmann et al.
CLINICAL CHEMISTRY (2014)
The Kidney Is the Principal Organ Mediating Klotho Effects
Karolina Lindberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study
Pablo Molina et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial
Gema Fernandez Juarez et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Circulating α-Klotho Levels in CKD and Relationship to Progression
Hyoung Rae Kim et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
25 (OH) Vitamin D Levels and Renal Disease Progression in Patients with Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System
Gema Fernandez-Juarez et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Evaluating Survey Quality in Health Services Research: A Decision Framework for Assessing Nonresponse Bias
Jonathon R. B. Halbesleben et al.
HEALTH SERVICES RESEARCH (2013)
Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease
Sarah Seiler et al.
KIDNEY INTERNATIONAL (2013)
The unequal health of Europeans: successes and failures of policies
Johan P. Mackenbach et al.
LANCET (2013)
Parathyroidectomy Improves Survival In Patients with Severe Hyperparathyroidism: A Comparative Study
Patricia Taschner Goldenstein et al.
PLOS ONE (2013)
Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study
Chiara Donfrancesco et al.
PLOS ONE (2013)
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial
Jessica A. Alvarez et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
Iefke Drion et al.
BMC NEPHROLOGY (2012)
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
Carsten A. Boeger et al.
PLOS GENETICS (2011)
Prevalence of CKD in Northeastern Italy: Results of the INCIPE Study and Comparison with NHANES
Giovanni Gambaro et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI Formulas in Relation to GFR, Age, and Body Size
Wieneke Marleen Michels et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Selection Bias and Information Bias in Clinical Research
Giovanni Tripepi et al.
NEPHRON CLINICAL PRACTICE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
Kathryn L. Adeney et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Multiple loci associated with indices of renal function and chronic kidney disease
Anna Koettgen et al.
NATURE GENETICS (2009)
Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients
Glen T. Schumock et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease
C. P. Kovesdy et al.
KIDNEY INTERNATIONAL (2008)
The pathophysiology of secondary hyperparathyroidism and the consequences of uncontrolled mineral metabolism in chronic kidney disease: the role of COSMOS
Jorge B. Cannata-Andia et al.
CLINICAL KIDNEY JOURNAL (2008)
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women:: Acute and 3-month effects on biomarkers of bone turnover
LB Tankó et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Effects of the selective oestrogen receptor modulator-raloxifene-on calcium and PTH secretory dynamics in women with osteoporosis
A Oleksik et al.
CLINICAL ENDOCRINOLOGY (2001)
Share Paper
